Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-267
Closed -$8K 286
2022
Q1
$8K Hold
267
﹤0.01% 279
2021
Q4
$8K Sell
267
-953
-78% -$111K ﹤0.01% 289
2021
Q3
$220K Hold
1,220
0.01% 266
2021
Q2
$275K Hold
1,220
0.01% 257
2021
Q1
$399K Hold
1,220
0.01% 232
2020
Q4
$324K Hold
1,220
0.01% 236
2020
Q3
$321K Buy
1,220
+400
+49% +$131K 0.01% 211
2020
Q2
$300K Buy
820
+267
+48% +$96.7K 0.01% 211
2020
Q1
$123K Hold
553
0.01% 218
2019
Q4
$237K Hold
553
0.01% 223
2019
Q3
$210K Buy
+553
New +$211K 0.01% 224

Other funds holding XCUR

Cannell & Co's XCUR Position: Q2 2022 in Review

Cannell & Co sold out of Exicure (XCUR) in Q2 2022, closing a stake of 267 shares — an estimated $8K sold.

Cannell & Co first reported a position in XCUR in Q3 2019 and held it in 11 quarters. The position peaked at $399K in Q1 2021. 18 funds tracked by Wall St. Rank hold XCUR as of Q2 2022.

  • Cannell & Co reported no remaining Exicure position as of Q2 2022 after selling out during the quarter.
  • Cannell & Co sold 267 Exicure shares in Q2 2022, an estimated $8K.
  • Cannell & Co first reported a position in Exicure in Q3 2019 and held it in 11 quarters.
  • Cannell & Co's Exicure position peaked at $399K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Exicure as of Q2 2022.

Based on Cannell & Co's 13F filing for Q2 2022, filed 8 Aug 2022.